Purchase Order HHSN261201700421P

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $12,130.80, with an award date of June 15, 2020 and ultimate completion date of June 20, 2021. Work is performed in San Diego, California. The order is for service agreement items on a firm fixed price basis with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $4,066.13 on December 4, 2017, with a completion date of January 31, 2018. The order covers a maintenance agreement for Illumina sequencing equipment. Work is performed in San Diego, California. The purchase order carries firm fixed price terms and no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $24,158.08 on October 19, 2017, with an ultimate completion date of November 19, 2018. Performance occurs at Bethesda, Maryland. The order is firm fixed price with no set-aside designation. Specific requirements are not detailed in the source material.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $26,357.76 on June 29, 2017, with an ultimate completion date of June 30, 2018. Work is performed in San Diego, California. The order covers sequencing reagents, consumables, or related biotechnology products and services. No set-aside category applied to this procurement.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $12,130.80 on June 11, 2020, with ultimate completion on June 14, 2021. The order covers a maintenance agreement on a firm fixed price basis. Work is performed in San Diego, California. No set-aside was used.</p>

<p>The National Cancer Institute issued a $24,867.60 delivery order to Illumina, Inc. on August 15, 2017, for biological kits. Place of performance is San Diego, CA 92122. The order has a firm fixed-price structure with an ultimate completion date of September 13, 2017.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $20,987.00 on August 31, 2017, with final completion scheduled for March 19, 2018. Performance takes place in Bethesda, Maryland. The order covers sequencing instruments, reagents, consumables, or bioinformatics software—Illumina's core product portfolio for federal genomic research applications. Pricing is firm fixed price with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $8,616.96 on August 9, 2017, for biological kits. Work is performed in San Diego, California. The order carries a firm fixed price structure with an ultimate completion date of September 6, 2017.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $8,616.96 on September 20, 2017, for biological kits. Place of performance is San Diego, California. The order is firm fixed price with an ultimate completion date of October 20, 2017.</p>

<p>The National Cancer Institute issued a $25,618.32 delivery order to Illumina, Inc. on August 15, 2018, with final completion on August 22, 2018.</p> <p>Place of performance is San Diego, CA 92122. The order is firm fixed price with no set-aside. The source does not identify the parent IDIQ or vehicle under which this delivery order was issued.</p>